70%Confidence
0Views
FDASource
2026-03-20Date
Summary
Midodrine Hydrochloride Tablets recall due to defective blister packaging highlights potential packaging integrity issues at Major Pharmaceuticals. This could affect patient medication stability and lead to temporary supply constraints for this blood pressure medication.
Actionable: Verify packaging integrity for Midodrine Hydrochloride Tablets from this manufacturer before distribution.
AI Confidence: 70%
Data Points
firmThe Harvard Drug Group LLC
classificationClass II
statusOngoing
distributionNationwide US.
productMidodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapol
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now